Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001357211-10-000002)

Filing Details

Accession Number:: 0001357211-10-000002
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-07-02 13:00:00
Reporting Period:: 2010-06-30

Filing Date:: 2010-07-02
Accepted Time:: 2010-07-02 11:34:06
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1159019	Stellar Pharmaceuticals Inc	SLXCF	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1357211	Marie Janice Clarke	8664 Parkhouse Drive Mt Brydges A6 N0L 1W0	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Shares	Acquisiton	2010-06-30	30,000	$0.65	102,222	No	4	E	Direct
Common Shares	Disposition	2010-06-30	21,800	$0.90	80,422	No	4	S	Direct
Common Shares	Acquisiton	2010-06-30	0	$0.00	10,000	No	4	P	Indirect	Owned by husband

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	E	Direct
No	4	S	Direct
No	4	P	Indirect	Owned by husband

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Shares	Share Options (right to buy)	Disposition	2010-06-30	30,000	$0.65	30,000	$0.65

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
45,000	2010-06-30	2010-06-30	No	4	M	Direct

Footnotes

Exercise price was Cdn$0.69, price has been converted to US$